Inflammatory bowel disease (IBD) is a disease with symptoms including weight loss, abdominal pain, bloody stools and persistent diarrhoea. According to current research, gut microbiota is considered to play an important role in IBD development. This analysis is of collected faecal samples from 43 children with IBD, specifically Crohn's disease (CD). MicrobiomeAnalyst software employing 16S rRNA sequencing was used to analyse the gut microbiota composition in the IBD patients, as well to enable comparison between the patients and a healthy control group. The analysis revealed that phylum Proteobacteria in the CD faecal samples was significantly higher than in the control, and also showed that abundance of genus Escherichia, species Coli and species Fragilis were also higher than in the control group without CD. This suggested that gut microbiota disorders are associated with intestinal inflammation. And while phylum Verrucomicrobia was present in the control group, it was apparently absent from the CD group. It was further found that Pseudomonas was positively correlated with Escherichia, while Faecalibacterium and Bacteroides were negatively correlated withEscherichia in the CD individuals. In addition, the diversity of gut microbiota among the individuals with CD was lower than for those without CD. It can be concluded that the disorder and the decrease in diversity of gut microbiota are related to intestinal inflammation, and specific relevant intestinal microbes are also evident.